EnteroBiotix is a leading microbiome therapeutics company with a mission to transform the lives of patients through best-in-class microbiome medicines. They offer a range of innovative products and services that are designed to deliver fast and effective treatment options for patients. Their technology platform is at the forefront of microbiome research, allowing them to develop cutting-edge therapies.

EnteroBiotix's pipeline includes a variety of promising candidates that are currently undergoing clinical trials. They have a dedicated team of experienced professionals, including scientists, researchers, and clinicians, who are passionate about improving patient outcomes. The company values of EnteroBiotix, including being ambitious for patients and committed to collaboration, guide every aspect of their work.

With their state-of-the-art facilities and commitment to integrity, EnteroBiotix is poised to revolutionize the field of microbiome medicine and make a significant impact on patient care